Evidence That the Protein Phosphatase Activity of PTEN Contributes to Embryonic Development and Tumor Suppression
Cancer Science · 2026-11 · 117 (11) · 2982-2996
DOI: 10.1111/cas.70476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 19.07.2026. Verfasst von Priyanka Tibarewal und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot Watt University, Edinburgh, UK. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Embryonic Development, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
PTEN (phosphatase and tensin homolog deleted on chromosome ten) is a tumor suppressor, the function of which is impaired in many diverse cancers. It has phosphoinositide lipid phosphatase activity by which it suppresses activation of the oncogenic PI3K signaling network but in vitro also displays activity against protein substrates and is able to auto‐dephosphorylate its Thr366 residue. Here we generate germline knock‐in mice expressing PTEN‐Y138L, a mutant enzyme which selectively lacks protein phosphatase activity and retains lipid phosphatase activity. Homozygous Pten Y138L/Y138L mice die in utero before E10.5. Primary MEFs and thymocytes with only a single Pten Y138L allele display normal low levels of AKT phosphorylation indicating effective regulation of PI3K signaling by endogenous PTEN‐Y138L in vivo. Heterozygous Pten +/Y138L mice have reduced overall survival compared to wild‐type littermates and develop tumors in multiple organs. Our data imply that in addition to its lipid phosphatase activity, the protein phosphatase activity of PTEN is also required for normal embryonic development and tumor suppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot Watt University, Edinburgh, UK.
- Division of Cell Signalling and Immunology, Faculty of Life Sciences, University of Dundee, Dundee, UK.
- Cancer Institute, University College London, London, UK.
- Division of Molecular, Cell and Developmental Biology, Faculty of Life Sciences, University of Dundee, Dundee, UK.
- Inositide Laboratory, Babraham Institute, Cambridge, UK.
ORCID-Profile: Karen E Anderson, Nicholas R Leslie
Förderung
- Medical Research Council
Zitieren
APA
Tibarewal, P., Spinelli, L., Kriplani, N., Wise, H., Poncet, N., Marzano, G., Anderson, K. E., Grzes, K. M., Varyova, Z., Adil, M., Downes, C. P., Hawkins, P. T., Stephens, L. R., Storey, K. G., Cantrell, D. A., Vanhaesebroeck, B., & Leslie, N. R. (2026). Evidence That the Protein Phosphatase Activity of PTEN Contributes to Embryonic Development and Tumor Suppression. Cancer Science, 117(11), 2982-2996. https://doi.org/10.1111/cas.70476
Vancouver
Tibarewal P, Spinelli L, Kriplani N, Wise H, Poncet N, Marzano G, et al. Evidence That the Protein Phosphatase Activity of PTEN Contributes to Embryonic Development and Tumor Suppression. Cancer Science. 2026;117(11):2982-2996. doi:10.1111/cas.70476
BibTeX
@article{Tibarewal2026,
author = {Tibarewal, Priyanka and Spinelli, Laura and Kriplani, Nisha and Wise, Helen and Poncet, Nadege and Marzano, Giulia and Anderson, Karen E and Grzes, Katarzyna M and Varyova, Zofia and Adil, Mahreen and Downes, C Peter and Hawkins, Phillip T and Stephens, Len R and Storey, Kate G and Cantrell, Doreen A and Vanhaesebroeck, Bart and Leslie, Nicholas R},
title = {Evidence That the Protein Phosphatase Activity of PTEN Contributes to Embryonic Development and Tumor Suppression},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {11},
pages = {2982--2996},
doi = {10.1111/cas.70476}
}
EUVIMED